Liabilities and Equity of BIO-TECHNE Corp from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
BIO-TECHNE Corp quarterly Liabilities and Equity in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIO-TECHNE Corp Liabilities and Equity for the quarter ending 31 Dec 2025 was $2,522,699,000, a 5.5% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,522,699,000 -$147,725,000 -5.5% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $2,526,148,000 -$209,869,000 -7.7% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $2,557,868,000 -$145,999,000 -5.4% 30 Jun 2025 10-Q 04 Feb 2026 2026 Q2
Q1 2025 $2,644,259,000 -$76,911,000 -2.8% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $2,670,424,000 -$60,329,000 -2.2% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $2,736,017,000 -$19,343,000 -0.7% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $2,703,867,000 +$65,175,000 +2.5% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $2,721,170,000 +$121,474,000 +4.7% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $2,730,753,000 +$367,352,000 +16% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $2,755,360,000 +$404,639,000 +17% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $2,638,692,000 +$343,887,000 +15% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $2,599,696,000 +$299,804,000 +13% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $2,363,401,000 +$58,555,000 +2.5% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $2,350,721,000 +$80,534,000 +3.5% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $2,294,805,000 +$31,848,000 +1.4% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $2,299,892,000 +$215,250,000 +10% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $2,304,846,000 +$236,980,000 +11% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $2,270,187,000 +$217,091,000 +11% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $2,262,957,000 +$235,368,000 +12% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $2,084,642,000 +$85,620,000 +4.3% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $2,067,866,000 +$69,451,000 +3.5% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $2,053,096,000 +$128,068,000 +6.7% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $2,027,589,000 +$143,179,000 +7.6% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $1,999,022,000 +$126,404,000 +6.8% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $1,998,415,000 +$153,583,000 +8.3% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $1,925,028,000 +$52,830,000 +2.8% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $1,884,410,000 +$291,208,000 +18% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q1 2019 $1,872,618,000 +$254,810,000 +16% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $1,844,832,000 +$289,410,000 +19% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $1,872,198,000 +$344,818,000 +23% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $1,593,202,000 +$34,983,000 +2.2% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q1 2018 $1,617,808,000 +$84,377,000 +5.5% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $1,555,422,000 +$35,397,000 +2.3% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $1,527,380,000 +$9,902,000 +0.65% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $1,558,219,000 +$428,638,000 +38% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q1 2017 $1,533,431,000 +$411,507,000 +37% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $1,520,025,000 +$386,572,000 +34% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $1,517,478,000 +$389,158,000 +34% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $1,129,581,000 +$66,221,000 +6.2% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q1 2016 $1,121,924,000 +$17,619,000 +1.6% 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $1,133,453,000 +$14,455,000 +1.3% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $1,128,320,000 +$110,060,000 +11% 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $1,063,360,000 +$200,869,000 +23% 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q1 2015 $1,104,305,000 +$273,739,000 +33% 31 Mar 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 $1,118,998,000 +$316,833,000 +39% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q2
Q3 2014 $1,018,260,000 +$238,970,000 +31% 30 Sep 2014 10-Q 10 Nov 2014 2015 Q1
Q2 2014 $862,491,000 +$84,393,000 +11% 30 Jun 2014 10-K 31 Aug 2015 2015 FY
Q1 2014 $830,566,000 +$70,276,000 +9.2% 31 Mar 2014 10-Q 12 May 2014 2014 Q3
Q4 2013 $802,165,000 +$77,595,000 +11% 31 Dec 2013 10-Q 04 Feb 2014 2014 Q2
Q3 2013 $779,290,000 +$66,661,000 +9.4% 30 Sep 2013 10-Q 12 Nov 2013 2014 Q1
Q2 2013 $778,098,000 +$58,774,000 +8.2% 30 Jun 2013 10-K 29 Aug 2014 2014 FY
Q1 2013 $760,290,000 +$76,256,000 +11% 31 Mar 2013 10-Q 10 May 2013 2013 Q3
Q4 2012 $724,570,000 +$100,322,000 +16% 31 Dec 2012 10-Q 11 Feb 2013 2013 Q2
Q3 2012 $712,629,000 +$84,193,000 +13% 30 Sep 2012 10-Q 09 Nov 2012 2013 Q1
Q2 2012 $719,324,000 +$101,654,000 +16% 30 Jun 2012 10-K 29 Aug 2013 2013 FY
Q1 2012 $684,034,000 +$101,215,000 +17% 31 Mar 2012 10-Q 10 May 2012 2012 Q3
Q4 2011 $624,248,000 +$68,640,000 +12% 31 Dec 2011 10-Q 07 Feb 2012 2012 Q2
Q3 2011 $628,436,000 +$88,812,000 +16% 30 Sep 2011 10-Q 09 Nov 2011 2012 Q1
Q2 2011 $617,670,000 +$98,854,000 +19% 30 Jun 2011 10-K 29 Aug 2012 2012 FY
Q1 2011 $582,819,000 31 Mar 2011 10-Q 10 May 2011 2011 Q3
Q4 2010 $555,608,000 31 Dec 2010 10-Q 09 Feb 2011 2011 Q2
Q3 2010 $539,624,000 30 Sep 2010 10-Q 09 Nov 2010 2011 Q1
Q2 2010 $518,816,000 30 Jun 2010 10-K 29 Aug 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.